生育市場規模、佔有率和成長分析：按治療類型、產品類型、手術類型、患者類型、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024 年全球生育市場價值 323 億美元，預計從 2025 年的 351 億美元成長到 2033 年的 683.2 億美元，預測期（2026-2033 年）的複合年成長率為 8.7%。

受人口結構變化（例如生育年齡延遲和不孕症上升）的推動，全球生育市場正經歷顯著成長。該領域涵蓋輔助生殖技術、診斷、藥物和捐卵服務，所有這些共同作用，旨在提高個人和夫婦的懷孕幾率。胚胎著床前遺傳學檢測 (PGT) 和先進的胚胎冷凍技術等創新正在改善臨床結果，從而提高成功率和累積效益，進而擴大市場。此外，企業生育支持計劃和卵子冷凍計劃也吸引了職業女性的關注，尤其是在都市區。生育旅遊也在興起，人們前往提供價格合理且先進的生育解決方案的國家，這促進了國際合作，並推動了對生育相關技術、數據分析和個人化治療方案的投資。

全球生育市場成長要素

隨著不孕症率的上升，對診斷、治療和輔助生育服務的需求日益成長，尋求幫助的人數也不斷增加。這種需求的激增促使診所和實驗室提升自身能力，拓展治療項目，以滿足不同患者的需求。此外，醫療機構正優先投資先進技術和專業培訓，以提高成功率，最終吸引更多患者，並鼓勵他們儘早尋求醫療建議。這一持續趨勢正在催生強勁的市場需求，並帶動相關產品、程序和服務在各個地區的持續使用。

全球生育市場中的限制因素

高昂的生育治療費用是許多人面臨的主要障礙，限制了他們獲得治療的機會，並阻礙了整個市場的成長。當患者需要承擔自付費用且保險覆蓋不足時，這些服務的經濟成本就會變得沉重，從而將需求限制在富裕人群中。這種需求集中阻礙了生育治療的普及，並減緩了其推廣速度。此外，高昂的費用還會阻礙及時干預，導致潛在患者延遲或放棄治療計劃，最終影響服務的長期可近性。因此，這種情況會縮小基本客群，並阻礙各地區的穩定成長，從而限制市場擴張。

全球生育市場趨勢

隨著數位科技和遠端醫療的融合發展，全球生育市場正經歷著一場意義深遠的變革。線上諮詢和遠端監測功能不僅能夠實現患者持續參與和個人化治療體驗，還能改善偏遠地區患者的就醫途徑。電子健康記錄和互通性資料的引入促進了醫療服務提供者之間的無縫協作，簡化了臨床決策和後續追蹤流程。這種轉變不僅重塑了診所的工作流程，也要求醫護人員培養符合以病人為中心的新能力。最終，這些創新將為差異化服務模式鋪平道路，優先考慮便利性、透明度和建立醫病信任。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球生育市場規模：依治療類型分類

• 輔助生殖技術（ART）
  • 體外受精（IVF）
  • 胞漿內單一精子注射（ICSI）
  • 冷凍胚胎移植（FET）
  • 利用卵子和精子捐贈進行治療
  • 代孕服務
• 人工授精
  • 子宮內人工授精（IUI）
  • 子宮頸內人工授精（ICI）
• 生育力保存
  • 冷凍卵子
  • 精子冷凍
  • 胚胎冷凍保存
• 生育藥物和荷爾蒙療法
  • 促排卵藥物
  • 促性腺激素分泌
  • 荷爾蒙支持療法

全球生育市場規模：依產品/服務類型分類

• 生育藥物
• 生育用品和培養基
• 生育設備
  • 影像系統
  • 培養箱
  • 微作業系統
  • 冷凍保存系統
• 不孕症檢查及診斷
• 生育診所提供的服務

全球生育市場規模：依手術類型分類

• 無供體的新周期
• 冷凍非供體週期
• 使用捐卵子的周期
• 供體胚胎週期
• 代孕母親週期

全球生育市場規模：依病患類型分類

• 女性不孕症
• 男性不孕
• 聯合不孕症
• 不明原因不孕
• 單親與 LGBTQ+ 家庭

全球生育市場規模：依最終用戶分類

• 不孕症治療診所
• 醫院
• 外科中心
• 冷凍保存庫及生育力保存中心
• 研究機構

全球生育市場規模：按通路分類

• 直接向機構競標和銷售
• 零售藥房
• 專科藥房
• 網路藥房

全球生育市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• CooperSurgical
• Vitrolife Group
• FUJIFILM Irvine Scientific
• Hamilton Thorne
• Cook Medical
• Thermo Fisher Scientific
• Kitazato Corporation
• Esco Medical
• Genea Biomedx
• Progyny
• IVI RMA Global
• Virtus Health
• Monash IVF Group
• Merck KGaA
• Ferring Pharmaceuticals
• Organon
• Gedeon Richter
• Bloom IVF Group
• Apollo Fertility
• Gaudium IVF

結論與建議

Global Fertility Market size was valued at USD 32.30 Billion in 2024 and is poised to grow from USD 35.10 Billion in 2025 to USD 68.32 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).

The global fertility market is experiencing significant growth, driven by demographic changes such as delayed childbearing and rising infertility rates. This sector encompasses assisted reproductive technologies, diagnostics, pharmaceuticals, and donor services, which collectively enhance individuals' and couples' chances of conception. Innovations like pre-implantation genetic testing (PGT) and advanced embryo freezing techniques have improved clinical outcomes, consequently expanding the market as success rates and cumulative cost efficiencies rise. Additionally, corporate fertility benefits and egg freezing programs have attracted career-focused women, particularly in urban settings. Fertility tourism is also on the rise, with individuals traveling to countries offering affordable and advanced fertility solutions, fostering international collaboration and investment in fertility-related technologies, data analytics, and customized treatment protocols.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fertility market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fertility Market Segments Analysis

Global fertility market is segmented by treatment type, product & service type, procedure type, patient type, end user, distribution channel and region. Based on treatment type, the market is segmented into assisted reproductive technology (ART), artificial insemination, fertility preservation and fertility drugs & hormonal therapy. Based on product & service type, the market is segmented into fertility drugs, fertility consumables & media, fertility equipment, fertility testing & diagnostics and fertility clinic services. Based on procedure type, the market is segmented into fresh non-donor cycles, frozen non-donor cycles, donor egg cycles, donor embryo cycles and gestational carrier cycles. Based on patient type, the market is segmented into female infertility, male infertility, combined infertility, unexplained infertility and single parents & LGBTQ+ families. Based on end user, the market is segmented into fertility clinics, hospitals, surgical centers, cryobanks & fertility preservation centers and research institutes. Based on distribution channel, the market is segmented into direct tender & institutional sales, retail pharmacies, specialty pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fertility Market

The increasing prevalence of infertility has led to a greater demand for diagnostic, therapeutic, and supportive fertility services, resulting in a larger number of individuals seeking assistance. This surge in need encourages clinics and laboratories to enhance their capabilities and broaden their treatment offerings to cater to diverse patient needs. Furthermore, healthcare providers are prioritizing investments in advanced technology and specialized training to boost success rates, ultimately drawing in more patients and prompting them to seek medical advice sooner. This ongoing trend fosters robust market demand, leading to continuous utilization of related products, procedures, and services throughout various regions.

Restraints in the Global Fertility Market

The high expenses related to fertility treatments create significant barriers for many individuals, restricting access and limiting overall market growth. When patients face substantial out-of-pocket costs and inadequate insurance coverage, the affordability of these services diminishes, leading to demand primarily from wealthier demographics. This concentration of demand hampers widespread utilization and results in slower adoption of fertility treatments. Additionally, elevated costs may discourage timely intervention, prompting potential patients to delay or abandon their treatment plans, ultimately impacting long-term service availability. Consequently, this situation restricts market expansion by reducing the customer base and impeding consistent growth across various regions.

Market Trends of the Global Fertility Market

The global fertility market is increasingly embracing digital and telehealth integration, significantly transforming the delivery of reproductive healthcare services. Virtual consultations and remote monitoring capabilities are enabling continuous patient engagement and personalized treatment experiences, while enhancing access for individuals in remote areas. The incorporation of electronic health records and interoperable data fosters seamless coordination among healthcare providers, streamlining clinical decision-making and follow-up processes. This shift not only redefines clinic workflows but also necessitates the development of new staff competencies that align with a patient-centric approach. Ultimately, these innovations pave the way for differentiated offerings that emphasize convenience, transparency, and nurturing therapeutic relationships.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Fertility Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Assisted Reproductive Technology (ART)
  • In Vitro Fertilization (IVF)
  • Intracytoplasmic Sperm Injection (ICSI)
  • Frozen Embryo Transfer (FET)
  • Donor Egg & Donor Sperm Procedures
  • Surrogacy Services
• Artificial Insemination
  • Intrauterine Insemination (IUI)
  • Intracervical Insemination (ICI)
• Fertility Preservation
  • Egg Freezing
  • Sperm Freezing
  • Embryo Cryopreservation
• Fertility Drugs & Hormonal Therapy
  • Ovulation Induction Drugs
  • Gonadotropins
  • Hormonal Support Therapy

Global Fertility Market Size by Product & Service Type & CAGR (2026-2033)

• Market Overview
• Fertility Drugs
• Fertility Consumables & Media
• Fertility Equipment
  • Imaging Systems
  • Incubators
  • Micromanipulation Systems
  • Cryopreservation Systems
• Fertility Testing & Diagnostics
• Fertility Clinic Services

Global Fertility Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Fresh Non-Donor Cycles
• Frozen Non-Donor Cycles
• Donor Egg Cycles
• Donor Embryo Cycles
• Gestational Carrier Cycles

Global Fertility Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Female Infertility
• Male Infertility
• Combined Infertility
• Unexplained Infertility
• Single Parents & LGBTQ+ Families

Global Fertility Market Size by End User & CAGR (2026-2033)

• Market Overview
• Fertility Clinics
• Hospitals
• Surgical Centers
• Cryobanks & Fertility Preservation Centers
• Research Institutes

Global Fertility Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Tender & Institutional Sales
• Retail Pharmacies
• Specialty Pharmacies
• Online Pharmacies

Global Fertility Market Size & CAGR (2026-2033)

• North America (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
  • US
  • Canada
• Europe (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Product & Service Type, Procedure Type, Patient Type, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CooperSurgical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Thorne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kitazato Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Biomedx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Progyny
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IVI RMA Global
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virtus Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Monash IVF Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gedeon Richter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bloom IVF Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apollo Fertility
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gaudium IVF
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations